EDOC:NSD-Global X Telemedicine & Digital Health ETF (USD)

ETF | Others |

Last Closing

USD 9.323

Change

0.00 (0.00)%

Market Cap

USD 0.04B

Volume

0.01M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-09 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
IBIT iShares Bitcoin Trust

+0.30 (+0.63%)

USD 45.40B
QQQM Invesco NASDAQ 100 ETF

-0.04 (-0.02%)

USD 39.18B
JEPQ JPMorgan Nasdaq Equity Premium..

-0.02 (-0.04%)

USD 22.49B
ACWI iShares MSCI ACWI ETF

+0.47 (+0.42%)

USD 18.95B
CGABL The Carlyle Group Inc. 4.625% ..

+0.05 (+0.30%)

USD 16.14B
SNDK Sandisk Corp

-0.74 (-2.31%)

USD 5.99B
TBIL Rbb Fund Inc - Us Treasury 3 M..

+0.03 (+0.06%)

USD 5.43B
TSLL Direxion Shares ETF Trust - Di..

-0.02 (-0.26%)

USD 4.44B
NVDL GraniteShares 1.5x Long NVDA D..

-1.95 (-5.99%)

USD 3.04B
ETHA iShares Ethereum Trust ETF

-0.03 (-0.25%)

USD 2.37B

ETFs Containing EDOC

HDOC:CA 98.44 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -5.16% 44% F 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return -5.16% 44% F 63% D
Trailing 12 Months  
Capital Gain 2.11% 71% C- 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.11% 55% F 62% D
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -13.48% 11% F 19% F
Dividend Return -13.48% 10% F 18% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 16.25% 36% F 81% B-
Risk Adjusted Return -82.98% 4% F 7% C-
Market Capitalization 0.04B 52% F 25% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.